AAAAAA

   
Results: 1-25 | 26-43 |
Results: 26-43/43

Authors: MOHLE R SALEMI P MOORE MAS RAFII S
Citation: R. Mohle et al., EXPRESSION OF INTERLEUKIN-5 BY HUMAN BONE-MARROW MICROVASCULAR ENDOTHELIAL-CELLS (BMEC) INDUCES LINEAGE-SPECIFIC PROLIFERATION OF EOSINOPHILS, Blood, 88(10), 1996, pp. 737-737

Authors: RAFII S MOHLE R ARMAN P MOORE MAS NACHMAN RL BERGSAGEL LP
Citation: S. Rafii et al., HUMAN BONE-MARROW MICROVASCULAR ENDOTHELIAL-CELLS (BMEC) REGULATE PROLIFERATION OF MYELOMA CELLS THROUGH GP130 RECEPTOR PATHWAY AND DIRECT CELLULAR CONTACT, Blood, 88(10), 1996, pp. 1170-1170

Authors: RAFII S FREY B MOHLE R MOORE MAS CRYSTAL RG
Citation: S. Rafii et al., CONSTITUTIVE OVEREXPRESSION OF THROMBOPOIETIN BY HUMAN BONE-MARROW ENDOTHELIAL-CELLS MAINTAINS LONG-TERM REGENERATION OF MEGAKARYOCYTES, Blood, 88(10), 1996, pp. 2512-2512

Authors: MOHLE R MUREA S KIRSCH M HAAS R
Citation: R. Mohle et al., DIFFERENTIAL EXPRESSION OF L-SELECTIN, VLA-4, AND LFA-1 ON CD34(-MARROW AND PERIPHERAL-BLOOD DURING G-CSF-ENHANCED RECOVERY() PROGENITOR CELLS FROM BONE), Experimental hematology, 23(14), 1995, pp. 1535-1542

Authors: MOHLE R PFORSICH M FRUEHAUF S WITT B KRAMER A HAAS R
Citation: R. Mohle et al., FILGRASTIM POSTCHEMOTHERAPY MOBILIZES MORE CD34(-STATE HEMATOPOIESIS (VOL 14, PG 827, 1994)() CELLS WITH A DIFFERENT ANTIGENIC PROFILE COMPARED WITH USE DURING STEADY), Bone marrow transplantation, 15(4), 1995, pp. 655-655

Authors: MOHLE R RAFII S SHOPIRO F OUERIJERO M CANDAL FJ KELLAR KL FERRIS B ASCH A MOORE MAS
Citation: R. Mohle et al., TRANSMIGRATION OF CD34-CELLS THROUGH IMMORTALIZED BONE-MARROW ENDOTHELIAL-CELLS( AND MATURE HEMATOPOIETIC), Blood, 86(10), 1995, pp. 1673-1673

Authors: RAFII S CANDAL FJ SHAPIRO F MOHLE R QUERIJERO M GREENBERG E FERRIS B NACHMAN RL BOSSE DC ADES EW MOORE MAS ASCH AS KELLAR KL
Citation: S. Rafii et al., IMMORTALIZED HUMAN BONE-MARROW MICROVASCULAR ENDOTHELIAL-CELLS (BMEC-1) SUPPORT LONG-TERM MULTILINEAGE HEMATOPOIESIS, Blood, 86(10), 1995, pp. 1967-1967

Authors: FRUEHAUF S HAAS R CONRADT C MUREA S WITT B MOHLE R HUNSTEIN W
Citation: S. Fruehauf et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COUNTS DURING STEADY-STATE HEMATOPOIESIS ALLOW TO ESTIMATE THE YIELD OF MOBILIZED PBPC AFTER FILGRASTIM (R-METHUG-CSF)-SUPPORTED CYTOTOXIC CHEMOTHERAPY, Blood, 85(9), 1995, pp. 2619-2626

Authors: HAAS R MOHLE R PFORSICH M FRUEHAUF S WITT B GOLDSCHMIDT H HUNSTEIN W
Citation: R. Haas et al., BLOOD-DERIVED AUTOGRAFTS COLLECTED DURING GRANULOCYTE-COLONY-STIMULATING FACTOR-ENHANCED RECOVERY ARE ENRICHED WITH EARLY THY-1(+) HEMATOPOIETIC PROGENITOR CELLS, Blood, 85(7), 1995, pp. 1936-1943

Authors: HAAS R WITT B MOHLE R GOLDSCHMIDT H HOHAUS S FRUEHAUF S WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., SUSTAINED LONG-TERM HEMATOPOIESIS AFTER MYELOABLATIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT, Blood, 85(12), 1995, pp. 3754-3761

Authors: HAAS R MOOS M KARCHER A MOHLE R WITT B GOLDSCHMIDT H FRUHAUF S FLENTJE M WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN LOW-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 12(8), 1994, pp. 1685-1692

Authors: MOHLE R PFORSICH M FRUEHAUF S WITT B KRAMER A HAAS R
Citation: R. Mohle et al., FILGRASTIM POSTCHEMOTHERAPY MOBILIZES MORE CD34(-STATE HEMATOPOIESIS() CELLS WITH A DIFFERENT ANTIGENIC PROFILE COMPARED WITH USE DURING STEADY), Bone marrow transplantation, 14(5), 1994, pp. 827-832

Authors: HAAS R HOHAUS S GOLDSCHMIDT H MOHLE R WITT B WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., HIGH-DOSE THERAPY AND AUTOGRAFTING WITH PERIPHERAL-BLOOD STEM-CELLS IN MALIGNANT-LYMPHOMA - GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR STEM-CELL MOBILIZATION, Seminars in oncology, 21(6), 1994, pp. 19-24

Authors: MOHLE R HAAS R HUNSTEIN W
Citation: R. Mohle et al., DIFFERENTIAL COEXPRESSION OF INTEGRINS AND SELECTINS ON BLOOD-DERIVEDAND BONE-MARROW CD34+ CELLS, Blood, 84(10), 1994, pp. 10000573-10000573

Authors: HAAS R WITT B MOHLE R GOLDSCHMIDT H HOHAUS S FRUHAUF S WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., SUSTAINED LONG-TERM HEMATOPOIESIS FOLLOWING MYELOABLATIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT, Blood, 84(10), 1994, pp. 10000710-10000710

Authors: HAAS R MOHLE R FRUHAUF S GOLDSCHMIDT H WITT B FLENTJE M WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., PATIENT CHARACTERISTICS ASSOCIATED WITH SUCCESSFUL MOBILIZING AND AUTOGRAFTING OF PERIPHERAL-BLOOD PROGENITOR CELLS IN MALIGNANT-LYMPHOMA, Blood, 83(12), 1994, pp. 3787-3794

Authors: MOHLE R HAAS R HUNSTEIN W
Citation: R. Mohle et al., FILGRASTIM-MOBILIZED CD34-BLOOD STEM-CELLS (PBSC) CONTAIN MORE PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS DURING STEADY-STATE HEMATOPOIESIS THAN POSTCHEMOTHERAPY( PERIPHERAL), Blood, 82(10), 1993, pp. 10000014-10000014

Authors: HAAS R MOHLE R FRUHAUF S GOLDSCHMIDT H THEILGAARDMONCH K WITT B HUNSTEIN W
Citation: R. Haas et al., AUTOGRAFTING WITH FILGRASTIM (R-METHUG-CSF)-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS (PBSC) IN MALIGNANT-LYMPHOMA - PREDICTIVE FACTORS FOR MOBILIZATION EFFICIENCY, Blood, 82(10), 1993, pp. 10000648-10000648
Risultati: 1-25 | 26-43 |